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Depression and ischaemic heart disease are not independent
entities. It has been demonstrated that depression is associated
with incident cardiovascular morbidity and mortality,1 and that
depression after myocardial infarction is prospectively associated
with an increased risk of adverse cardiac outcomes.2 Although this
latter finding has led researchers to believe that this reflects a
relatively simple causal effect of depression on cardiovascular
disease and its progression, by now the status of that hypothesis
is uncertain: several large-scale attempts in which depression in
cardiac patients was treated have concluded that no positive effects
on cardiac outcomes could be attributed to psychiatric treatment.3
The elegant study by A˚berg and colleagues in this issue of the
British Journal of Psychiatry4 represents the other side of the coin,
emphasising that the association between depression and cardio-
vascular disease may develop in the opposite direction. In a very
large sample of young men enlisted for military service, the
authors showed that cardiovascular fitness predicted the onset of
serious depression in adulthood. By controlling for several
confounders they made it less plausible that the observed effects
were the result of shared risk factors such as obesity, low level of
parental education, and familial influences. The suggestion of
cardiovascular parameters affecting depression is not new in itself
and falls well within a whole line of research such as the vascular
depression hypothesis in which vascular factors are held responsible
for the development of depression in older adults. Empirically, it
is known that depression prevalence is considerably higher
in patients with cardiovascular disease than in the general
population. However, the study by A˚berg et al goes well beyond
these findings, as the authors demonstrate that already in young
healthy men who are free of any form of clinical or subclinical
cardiovascular disease, lower cardiovascular fitness as assessed
during ergometer cycling is associated with future risk of incident
depression. Thus, the authors make a compelling case for the
depressogenic effects of low cardiovascular fitness even in the
absence of confounding factors related to cardiovascular disease.
In this editorial we make the case that simple chicken-or-egg
models in which depression causes cardiovascular disease or vice
versa in our opinion will turn out to be inadequate to address
all scientific data in this field. The available literature as a whole
may best be summarised with a hypothetical model describing
the association between depression and cardiovascular disease as
the outcome of two intertwined, mutually reinforcing disorders
of which the roots may lie already in youth. The study by A˚berg
and colleagues adds substantially to the body of literature supporting
this notion using an exceptionally strong research design.
How does this translate to clinical practice?
Based on the study by A˚berg et al, researchers with clinical ambitions
may start to develop interventions aimed at cardiovascular
parameters in an attempt to prevent or ameliorate depression,
now that the reverse strategy has turned out largely unsuccessful.
However, we believe such an approach is likely to fail as well.
Instead, we favour an approach in which the complex nature of
the association between depression and cardiovascular disease is
taken well into account, based on the following reasoning.
First, information on mechanisms underlying the relationship
between cardiovascular disease and depression, and therefore
information on specific targets for intervention, is incomplete.
This is problematic as ideally this type of research would provide
the targets for effective interventions. In the literature, numerous
potentially mediating mechanisms have been proposed and these
include psychophysiological factors such as reduced heart rate
variability, inflammatory processes, disturbed platelet function
and hypothalamus–pituitary–adrenal (HPA) axis dysfunction,
and behavioural factors such as physical inactivity, unhealthy diet,
smoking and poor medication adherence.5 As depression and
cardiovascular disease are both multifactorial and heterogeneous
disorders, it is unlikely that any specific factor will explain a
substantial part of the association between depression and
cardiovascular disease. The literature in this field is still limited,
as the abovementioned potential mediators are mostly studied
in isolation while in reality they are all interrelated. Furthermore,
the directions of potential mediational pathways are far from
clear. In principle, these mechanisms are largely non-specific to
the direction of the association, and may explain both cardiotoxic
effects of depression and depressogenic effects of cardiovascular
fitness. For example, depressive symptoms may lead to
inflammation, but might also be the result of inflammatory
processes. The same holds for behavioural factors such as physical
activity and obesity. Directions of effects may even differ
between individuals. Finally, genetic factors may underlie the
development of both cardiovascular disease and depression,
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Summary
In this editorial, we propose that the association between
depression and cardiovascular disease may be
conceptualised as a continuous, bidirectional process that
originates in youth. The paper by A˚berg and colleagues
in this issue adds to this literature showing that low
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representing yet another kind of mediation, namely by a factor
that was already present before depression and cardiovascular
disease were. In sum, we still know little of the nature of the
association between the two intertwined disorders, and there is
little to support that a one-size-fits-all approach will be the
solution to improve the prognosis of the two.
A second factor that adds to the complexity of translating
these findings into effective interventions is the heterogeneity of
the depression construct. Since its operationalisation in the
DSM-III, numerous attempts have been made to detect relevant
depression subtypes in terms of severity, symptom patterns and
aetiologies. In cardiac patients, a differentiation in somatic and
cognitive symptom dimensions of depression is often reported
in which the somatic dimension is more strongly predictive of
cardiac prognosis.6 Notably, symptom dimensions of distress also
appear to be differentially related to potential mechanisms (e.g.
heart rate variability and HPA axis dysregulation), with somatic
symptoms being more intertwined with cardiovascular disease
than cognitive symptoms of depression.7 This line of research
suggests that underlying mechanisms linking depression and cardio-
vascular disease may be differentially involved across individuals.
To positively influence depression and/or cardiovascular disease,
different treatments may thus be required depending on
depression subtype and mediating factors. Although this field of
research is rather young and inconclusive, we feel that it holds
promise for addressing the depression–cardiovascular disease
association in clinical care.
The solution: no more simple models
We believe that simple models with respect to aetiology and thus
treatment of depression or cardiovascular fitness will turn out to
be inadequate and even hamper progress in this field. New models
are needed in which the bidirectionality of the association,
heterogeneity of depression, interdependency of mediators and
inter-individual heterogeneity in the association is accounted
for. Depression and cardiovascular disease are highly intertwined
diseases which continuously influence each other. The inter-
individual heterogeneity of the association implies that, for
instance, an underlying process such as atherosclerosis-based
inflammation might lead to cardiovascular disease followed by a
higher risk of depression in one individual, and depression
followed by a higher risk of heart disease in another. In a third
individual, atherosclerosis may even result from depression and
subsequent poor lifestyle. To deal with this in clinical care, and as
opposed to previously proposed simple models, we argue for an
alternative research approach based on the following foundations.
(a) Research to date supports bidirectional associations between
depression and cardiovascular parameters throughout the
life span. Scientific progress on concepts that are so much
intertwined will not be achieved by clinging to simple
hypotheses stressing only one side of the story. Instead of
treating one disorder in order to improve prognosis of the
other, we need to treat both simultaneously.
(b) The massive interdependencies between physiological and
behavioural mediators explaining the association between
depression and cardiovascular disease suggest that networks
of effects may give a far more complete representation of
reality. In addition, research should take into account
potential bidirectional effects of mechanisms. This argues for
interventions that are relatively unselective, i.e. affecting
several mechanisms simultaneously.
(c) The heterogeneity of the depression construct suggests that any
attempt to improve cardiovascular parameters in order to
influence depression, or to reduce depression in order to
improve cardiovascular parameters, should be adjustable to
the level of individuals.
Collaborative care and personalised medicine, in which
depression and cardiovascular disease are not conceptualised as
separate entities and in which interventions can be adjusted to
the stages of the disease, in principle might offer the opportunity
to address these issues. Lifestyle interventions including exercise
therapy will likely play an important role in such programmes
as they have the potential to improve depression and cardio-
vascular fitness simultaneously and may affect several of the
proposed mediators simultaneously. Research to date has shown
that collaborative care may be an effective tool in addressing
depression in the general population,8 but also depression as a
comorbid disorder in patients with somatic diseases.9 Still,
collaborative care is not a golden solution in itself, and its active
ingredients are far from being fully understood.10 The true
effectiveness of collaborative care in specific patients will depend
on how well clinicians are able to adjust the interventions to the
needs of individuals, based on a thorough understanding of the
association between depression and cardiovascular fitness within
individuals. Needless to say perhaps, this may hold for the
depression–cardiovascular disease link as well as for the link
between depression and other medical conditions.
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